Skip to main content
. 2021 May 7;70(5):001363. doi: 10.1099/jmm.0.001363

Fig. 5.

Fig. 5.

Molecular structure of manganese-based antibacterial compounds. (31)–(35) Mn(I) tricarbonyl complexes with ketoconazole, miconazole and clotrimazole ligands. The general formula of the Mn(I) tricarbonyl compounds is [Mn(CO)3(bpyH,COOCH 3)(azole)]PF6 where azole=the antibiotic ligand and bpy=bipyridine. The red box highlights azole ligand. The blue box indicates 2,2’-bpy ligands. (36)–(39) Mn(II) and Cu(II) complexes containing 1,10-phenanthroline and dicarboxylate ligands. (36) and (38) use Mn(II), (37) and (39) are the Cu(II) counterparts, respectively. (36) [Mn2(oda)(phen4)(H2O)2][Mn2(oda)(phen)4(oda2]·4H2O, (37) [Cu2(oda)(phen)4](ClO4)2·2.76H2O·EtOH, (38) [(Mn(3,6,9-tdda)(phen)2)·3H2O·EtOH]n, (39) [(Cu(3,6,9-tdda)(phen)2)·3H2O·EtOH]n. Figure adapted from the literature [177, 178].